performane

Zacks Investment Research Lowers Osiris Therapeutics, Inc. (OSIR) to Sell

By Jeff Rose Zacks Investment Research lowered shares of Osiris Therapeutics, Inc. (NASDAQ:OSIR) from a hold rating to a sell…